Forgot to mention @Cougar1311 I forgot to mention warrants. They are similar to ASX options. We would like to see a sustained CRML share price between 15-20, more than $20 would be awesome. We'll then exercise warrants at $11.50 each.
EUR will be issued more shares if this lasts for 3months or more - I don't believe these particular shares are subject to lock out. EUR can sell them straight away at market to raise capital (just like any other CRML shareholder). I say "we" because my portfolio has CRML warrants (that's why we redeemed). Hope this gave you a little more understanding that although dominos are not falling sequentially as planned... they are nevertheless, falling. It's hard to align such things as CRMA and Nasdaq IPO 1.5yrs ago. Each unlocks/adds value.
A reminder, we're listed at Nasdaq to raise capital because ASX had its chance and lost it. Nasdaq also values startups of its perceived value in the future and in multiples eg. if future looks bright, we could be valued at $2B-$5B if not more OR if future looks dim, we could be shorted to $1 per share to bankruptcy.
Given CRMA and EU's "self sufficiency" goal but not having enough mine, chances are good Wolfsberg project is a "strategic project" as would any explorer/developer with proven resource.
- Forums
- ASX - By Stock
- EUR
- General Discussion
General Discussion, page-919
Featured News
Add EUR (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.4¢ |
Change
-0.002(7.69%) |
Mkt cap ! $33.55M |
Open | High | Low | Value | Volume |
2.5¢ | 2.5¢ | 2.3¢ | $40.47K | 1.694M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 883452 | 2.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.4¢ | 224472 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 883452 | 0.023 |
7 | 309363 | 0.022 |
7 | 1443000 | 0.021 |
8 | 989644 | 0.020 |
1 | 25000 | 0.019 |
Price($) | Vol. | No. |
---|---|---|
0.024 | 224472 | 1 |
0.025 | 125296 | 1 |
0.026 | 504106 | 3 |
0.027 | 195890 | 1 |
0.028 | 100000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
EUR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online